Skip to main content
Gerald Voss

Gerald Voss

Gerald Voss is the Scientific Director of the TuBerculosis Vaccine Initiative (TBVI) in Lelystad, the Netherlands, and the Executive Director of the life sciences and coaching consultancy, SciPeo Srl, Science & People, in Grez-Doiceau, Belgium.

Gerald previously served as the Interim Director of the Global HIV Vaccine Enterprise in New York, USA.

In the past, he was with GSK vaccines in Rixensart, Belgium, overseeing the R&D portfolio for Diseases of the Developing World. During his tenure, Gerald established and lead product development partnerships in HIV, TB and malaria with the International AIDS Vaccine Initiative, Aeras, the Malaria Vaccine Initiative and the Bill & Melinda Gates Foundation.

Gerald holds a PhD in biology from Göttingen University, Germany, and received his postdoctoral training at Harvard Medical School in Boston, USA.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.